DSS, Inc. (DSS) is a publicly traded Consumer Cyclical sector company. As of July 26, 2026, DSS trades at $0.55 with a market cap of $5.52M and a P/E ratio of 0.00. DSS moved -2.14% today. Year to date, DSS is -42.71%; over the trailing twelve months it is -52.99%. Its 52-week range spans $0.36 to $1.90. Rallies surfaces DSS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
DSS Withdraws Form S-1 Registration, Plans New Financing and Impact Biomedical Merger: DSS, Inc. has withdrawn its Form S-1 registration with the SEC after finding market conditions and deal terms inadequate to reflect its value. The company says it can access capital markets on more favorable terms and will continue evaluating financing alternatives and its planned Impact Biomedical merger.
| Metric | Value |
|---|---|
| Price | $0.55 |
| Market Cap | $5.52M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.90 |
| 52-Week Low | $0.36 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $20.14M |
| Net Income | $-28.59M |
| Gross Margin | 0.00% |
DSS analyst coverage data. Average price target: $0.00.